Jeanette Wood
Chairman at RocketVax AG
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Vladimir Cmiljanovic | M | - |
RocketVax AG
 RocketVax AG BiotechnologyHealth Technology RocketVax AG develops vaccines. The company is based in Basel, Switzerland. The Swiss company was founded in 2020 by Vladimir Cmiljanovic. Vladimir Cmiljanovic has been the CEO since 2020. | 4 years |
| Elias Papatheodorou | M | 55 |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | 9 years |
| Pascal Soriot | M | 64 |
AstraZeneca UK Ltd.
 AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. | 12 years |
| Thomas Ladner | M | - |
RocketVax AG
RocketVax AG BiotechnologyHealth Technology RocketVax AG develops vaccines. The company is based in Basel, Switzerland. The Swiss company was founded in 2020 by Vladimir Cmiljanovic. Vladimir Cmiljanovic has been the CEO since 2020. | 4 years |
| Samir Shah | M | 63 | 20 years | |
| Vasant Narasimhan | M | 48 | 19 years | |
| Pascal Claude Roland Soriot | - | - |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. | 12 years |
| Natasa Cmiljanovic | M | - |
RocketVax AG
RocketVax AG BiotechnologyHealth Technology RocketVax AG develops vaccines. The company is based in Basel, Switzerland. The Swiss company was founded in 2020 by Vladimir Cmiljanovic. Vladimir Cmiljanovic has been the CEO since 2020. | 4 years |
| Marco Illy | M | - |
RocketVax AG
RocketVax AG BiotechnologyHealth Technology RocketVax AG develops vaccines. The company is based in Basel, Switzerland. The Swiss company was founded in 2020 by Vladimir Cmiljanovic. Vladimir Cmiljanovic has been the CEO since 2020. | - |
| Marc Dunoyer | M | 71 |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. | 11 years |
| Christoph Brutschin | M | 66 |
RocketVax AG
RocketVax AG BiotechnologyHealth Technology RocketVax AG develops vaccines. The company is based in Basel, Switzerland. The Swiss company was founded in 2020 by Vladimir Cmiljanovic. Vladimir Cmiljanovic has been the CEO since 2020. | 3 years |
| Harry Werner Kirsch | M | 59 | 21 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Giancarlo Mocchi | M | 84 |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | 29 years |
| Wendelin Wiedeking | M | 72 | 11 years | |
| Ronen Tamir | M | 57 | - | |
| Jürgen Brokatzky-Geiger | M | 72 |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | 28 years |
| Rolf M. Zinkernagel | M | 80 | 15 years | |
| Ulrich Lehner | M | 78 | 13 years | |
| Pierre Landolt | M | 77 | 22 years | |
| Peter Burckhardt | M | - | - | |
| Juan Andres | M | 59 | 12 years | |
| Thomas Wellauer | M | 69 | - | |
| Peter Kornicker | M | - | 20 years | |
| Andreas von Planta | M | 68 | - | |
| Oliver Strub | M | 61 |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | 11 years |
| Gary Phillips | M | 62 |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | 6 years |
| Srikant T. Madhav Datar | M | 70 | 18 years | |
| Alexandre F. Jetzer-Chung | M | 83 | 15 years | |
| Sabri Markabi | M | - |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | - |
| John Martin Manser | M | 77 |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | 17 years |
| Joachim P. H. Schupp | M | 71 |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | 19 years |
| Hans Jörg Reinhardt | M | 68 | 28 years | |
| Daniel Vasella | M | 70 | 17 years | |
| Lisa Anson | F | - |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. | - |
| Gary Sutton | M | - | 13 years | |
| Vic Myer | M | - | 11 years | |
| Brian McNamara | M | 57 | - | |
| Carlos Garcia-Echeverria | M | 60 | 12 years | |
| Stefan Blarer | M | - | 10 years | |
| Atul Khosia | M | - | - | |
| Alessandro Riva | M | 63 | 11 years | |
| Benoit Dubuis | M | - | - | |
| Mauro Ghilardi | M | 57 | 9 years | |
| Edward Vlacich | M | - | - | |
| Steven Baert | M | 50 | 15 years | |
| Jonathan Peacock | M | 66 | 5 years | |
| Muriel Cottard | M | - | 14 years | |
| Eric Floyd | M | 62 | - | |
| Ginger Gregory | M | 56 | 7 years | |
| Armand Sohet | M | 59 | 1 years | |
| Brian Hubbard | M | - | 6 years | |
| Martin G. Friedman | M | - | 1 years | |
| Frédéric Guerard | M | 51 | 20 years | |
| Royston Glasspool | M | 61 | 10 years | |
| Anjana Harve | F | - | 14 years | |
| Gina Massa Mias | F | - | - | |
| Megan Wherry Menner | F | - | 4 years | |
| John Hohneker | M | 64 | 14 years | |
| Larry P. Allgaier | M | - | 6 years | |
| Malte Peters | M | 61 | 11 years | |
| Theresa Matkovits | M | 56 | 13 years | |
| Kevin Smith | M | - | 1 years | |
| Udit Batra | M | 53 | 2 years | |
| Marshall E. Reese | M | 78 | 5 years | |
| Monika Matti | F | - | - | |
| Norman Hardman | M | 78 | - | |
| Birgit Breuel | M | - | - | |
| Helmut Sihler | M | - | - | |
| Thomas Ebeling | M | 65 | 7 years | |
| Paul Choffat | M | - | 5 years | |
| Urs Bärlocher | M | 82 | 11 years | |
| Silke Zentner | F | - | - | |
| Kenneth R. Shaw | M | - |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | 25 years |
| Johannes M. Respondek | M | 70 | 1 years | |
| Anders Hove | M | 58 | 4 years | |
| Paul Herrling | M | 78 | - | |
| Raymund Breu | M | 79 | 14 years | |
| William George | M | 81 | 10 years | |
| Sarah Boyce | F | 52 | 10 years | |
| George Gunn | M | 74 | 12 years | |
| Thomas Werlen | M | - | 5 years | |
| Ian Garland | M | 59 | - | |
| Jessica Mann | M | - | - | |
| Joy Zhu | M | - |
S*BIO Pte Ltd.
 S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. | 5 years |
| Thomas McCourt | M | 66 | 7 years | |
| Mason W. Freeman | M | 73 | 2 years | |
| Fredrik Ollila | M | - | - | |
| Peder Sven Walberg | M | 50 | 2 years | |
| Ludwig Hantson | M | 61 | 9 years | |
| Frank Palantoni | M | 66 | 6 years | |
| Charl van Zyl | M | 57 | 3 years | |
| Mihael Polymeropoulos | M | 64 | 5 years | |
| Philippe Weigerstorfer | M | 64 | - | |
| Guy Rousseau | M | - | 6 years | |
| Sheldon Jones | M | - | - | |
| Ann Bailey | F | - | - | |
| Steven Kelmar | M | 70 | 4 years | |
| John McKenna | M | - | - | |
| Andreas Rummelt | M | 67 | 4 years | |
| Richard Glynne | M | - | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Switzerland | 95 | 95.00% |
| United Kingdom | 4 | 4.00% |
| Singapore | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jeanette Wood
- Personal Network